Janssen Pharmaceutical Companies
-
Janssen presents results of biologic therapies in patients with Crohn’s Disease
The SEAVUE study examined a total of 386 patients with moderately to severely active CD patients The Janssen Pharmaceutical Companies…
Read More » -
Janssen presents data from Phase 1 study of Talquetamab
The drug will be used in the treatment of relapsed or refractory multiple myeloma The Janssen Pharmaceutical Companies of Johnson…
Read More »